Leupeptin treatment reversed cardiac fibrosis inhibition as evidenced by lager fibrosis area and higher expression of Col1, Col3, MMP9, MMP2, and TGF-β1 than the control PBS treatment in LRP6 overexpressing hearts after TAC (Figure 8A, 8B). The gene discussed is TGFB1; the disease is persistent truncus arteriosus.